Don't Miss FDA's Oct. 11 Grand Rounds on the science behind a nicotine tobacco product standard. CE Credit Available

The October 11 FDA Grand Rounds Presents:

 

The Science to Inform a Tobacco Product Standard for the Level of Nicotine in Combusted Cigarettes. CE Credit Available

Thursday, October 11, 2018

12:00 p.m. - 1:00 p.m. EST

 

Register here for webcast (public attendees and FDA staff)

 

Presented by 

 

Lynn Hull, PhD

Lead Pharmacologist

FDA’s Center for Tobacco Products

 

About the Presentation

 

Dr. Hull will give an overview of the systematic literature review done by FDA’s Center for Tobacco Products on the likely effects of reducing nicotine in combusted tobacco -- and on consumer knowledge, attitudes, perceptions, beliefs, and planned behavior on reduced nicotine tobacco products.

Use of combusted tobacco products like cigarettes, kreteks, bidis, cigarette tobacco, roll-your-own tobacco, cigars, pipe tobacco, and water pipe tobacco causes a heavy burden of death and disease each year. These negative health effects are ultimately the result of users’ addiction to the nicotine in tobacco products, which in turn results in their repeated use. This continuously exposes users and non-users (via second- or third-hand smoke) to toxicants in the smoke. 

FDA has issued an Advanced Notice of Proposed Rulemaking for a product standard to set a maximum nicotine level in cigarettes. The Agency continues to assess the best available science to determine a level at which these products would be minimally addictive and, therefore, appropriate for protecting the public health